Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
June 11, 2016
Deep sequencing increases hepatitis C virus phylogenetic cluster detection compared to Sanger sequencing
Vincent Montoya, Andrea Olmstead, Patrick Tang, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
August 6, 2002
Problems with the fast-check HIV rapid test kits
Michael L Rekart, Mel Krajden, Darrel Cook, et al.
International Journal of STD & AIDS
|
July 19, 2014
Probability of a false-negative HIV antibody test result during the window period: a tool for pre- and post-test counselling
Darlene Taylor, Monica Durigon, Heather Davis, et al.
Clinical and Vaccine Immunology : CVI
|
October 16, 2009
Prevalence of human papillomavirus 16 and 18 neutralizing antibodies in prenatal women in British Columbia
Mel Krajden, Karuna Karunakaran, Stacy So, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 27, 2021
Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British Columbia, Canada
Mawuena Binka, Zahid Ahmad Butt, Geoffrey McKee, et al.
The Journal of Infectious Diseases
|
July 25, 2012
Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED
Manon Ragonnet-Cronin, Stéphane Aris-Brosou, Isabelle Joanisse, et al.
Ebiomedicine
|
September 7, 2016
The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
Naveed Z Janjua, Margot Kuo, Amanda Yu, et al.
Clinical and Vaccine Immunology : CVI
|
January 21, 2011
Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial
Mel Krajden, Darrel Cook, Amanda Yu, et al.
Microbiology Spectrum
|
June 6, 2022
British Columbia's Experience after Implementation of the Treponema pallidum Reverse Algorithm and PCR Detection, 2015 to 2020
Muhammad Morshed, Min-Kuang Lee, Jonathan Laley, et al.
Vaccine
|
September 24, 2013
Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial
Mel Krajden, Darrel Cook, Amanda Yu, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
June 11, 2016
Deep sequencing increases hepatitis C virus phylogenetic cluster detection compared to Sanger sequencing
Vincent Montoya, Andrea Olmstead, Patrick Tang, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
August 6, 2002
Problems with the fast-check HIV rapid test kits
Michael L Rekart, Mel Krajden, Darrel Cook, et al.
International Journal of STD & AIDS
|
July 19, 2014
Probability of a false-negative HIV antibody test result during the window period: a tool for pre- and post-test counselling
Darlene Taylor, Monica Durigon, Heather Davis, et al.
Clinical and Vaccine Immunology : CVI
|
October 16, 2009
Prevalence of human papillomavirus 16 and 18 neutralizing antibodies in prenatal women in British Columbia
Mel Krajden, Karuna Karunakaran, Stacy So, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 27, 2021
Differences in risk factors for hepatitis B, hepatitis C, and human immunodeficiency virus infection by ethnicity: A large population-based cohort study in British Columbia, Canada
Mawuena Binka, Zahid Ahmad Butt, Geoffrey McKee, et al.
The Journal of Infectious Diseases
|
July 25, 2012
Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED
Manon Ragonnet-Cronin, Stéphane Aris-Brosou, Isabelle Joanisse, et al.
Ebiomedicine
|
September 7, 2016
The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
Naveed Z Janjua, Margot Kuo, Amanda Yu, et al.
Clinical and Vaccine Immunology : CVI
|
January 21, 2011
Human papillomavirus 16 (HPV 16) and HPV 18 antibody responses measured by pseudovirus neutralization and competitive Luminex assays in a two- versus three-dose HPV vaccine trial
Mel Krajden, Darrel Cook, Amanda Yu, et al.
Microbiology Spectrum
|
June 6, 2022
British Columbia's Experience after Implementation of the Treponema pallidum Reverse Algorithm and PCR Detection, 2015 to 2020
Muhammad Morshed, Min-Kuang Lee, Jonathan Laley, et al.
Vaccine
|
September 24, 2013
Assessment of HPV 16 and HPV 18 antibody responses by pseudovirus neutralization, Merck cLIA and Merck total IgG LIA immunoassays in a reduced dosage quadrivalent HPV vaccine trial
Mel Krajden, Darrel Cook, Amanda Yu, et al.
Page
of 5